Empirical antimicrobial therapy for bloodstream infections not compliant with guideline was associated with discordant therapy, which predicted poorer outcome even in a low resistance environment

References

• Goto M, Al-Hasan MN. Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe. Clin Microbiol Infect. 2013;19(6):501–509.
   PubMed Web of Science ®Google Scholar
• Kadri SS, Lai YL, Warner S, et al. Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals. Lancet Infect Dis. 2021;21(2):241–251.
   PubMed Web of Science ®Google Scholar
• Marquet K, Liesenborgs A, Bergs J, et al. Incidence and outcome of inappropriate in-hospital empiric antibiotics for severe infection: a systematic review and meta-analysis. Crit Care. 2015;19(1):63.
   PubMedGoogle Scholar
• Paul M, Shani V, Muchtar E, et al. Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis. Antimicrob Agents Chemother. 2010;54(11):4851–4863.
   PubMed Web of Science ®Google Scholar
• Fleischmann C, Scherag A, Adhikari NK, et al. Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations. Am J Respir Crit Care Med. 2016;193(3):259–272.
   PubMed Web of Science ®Google Scholar
• Knoop ST, Skrede S, Langeland N, et al. Epidemiology and impact on all-cause mortality of sepsis in norwegian hospitals: a national retrospective study. PLOS One. 2017;12(11):e0187990.
   PubMed Web of Science ®Google Scholar
• Esposito S, De Simone G, Boccia G, et al. Sepsis and septic shock: new definitions, new diagnostic and therapeutic approaches. J Glob Antimicrob Resist. 2017;10:204–212.
   PubMed Web of Science ®Google Scholar
• Berild D, Mohseni A, Diep LM, et al. Adjustment of antibiotic treatment according to the results of blood cultures leads to decreased antibiotic use and costs. J Antimicrob Chemother. 2006;57(2):326–330.
   PubMed Web of Science ®Google Scholar
• Ferrer R, Martin-Loeches I, Phillips G, et al. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program*. Crit Care Med. 2014;42(8):1749–1755.
   PubMed Web of Science ®Google Scholar
• Abushaheen MA, Fatani AJ, Alosaimi M, et al. Antimicrobial resistance, mechanisms and its clinical significance. Dis Mon. 2020;66(6):100971.
   PubMed Web of Science ®Google Scholar
• Guo Y, Gao W, Yang H, et al. De-escalation of empiric antibiotics in patients with severe sepsis or septic shock: a meta-analysis. Heart Lung. 2016;45(5):454–459.
   PubMed Web of Science ®Google Scholar
• Turnidge J. Impact of antibiotic resistance on the treatment of sepsis. Scand J Infect Dis. 2003;35(9):677–682.
   PubMed Web of Science ®Google Scholar
• NORM/NORM-VET 2019. Usage of antimicrobial agents and occurence of antimicrobial resistance in Norway. Tromsø/Oslo; 2020.
   Google Scholar
• Antibiotika i sykehus Oslo: Helsedirektoratet; 2018. [cited 2021 9.11]. Available from: https://www.helsedirektoratet.no/retningslinjer/antibiotika-i-sykehus/sepsis.
   Google Scholar
• Jakovljev A, Bergh K. Development of a rapid and simplified protocol for direct bacterial identification from positive blood cultures by using matrix assisted laser desorption ionization time-of- flight mass spectrometry. BMC Microbiol. 2015;15:258.
   PubMed Web of Science ®Google Scholar
• Matuschek E, Brown DF, Kahlmeter G. Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories. Clin Microbiol Infect. 2014;20(4):O255–66.
   PubMed Web of Science ®Google Scholar
• The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters, version 10.0, 2020. [cited 2021 Oct 11]. Available from: https://www.eucast.org.
   Google Scholar
• Nordic Committee on Antimicrobial Suceptibility Testing NordicAST; 2020. [cited 2021 Oct 11]. Available from: http://www.nordicast.org/index.
   Google Scholar
• Mehl A, Asvold BO, Kummel A, et al. Trends in antimicrobial resistance and empiric antibiotic therapy of bloodstream infections at a general hospital in Mid-Norway: a prospective observational study. BMC Infect Dis. 2017;17(1):116.
   PubMedGoogle Scholar
• Mehl A, Åsvold BO, Lydersen S, et al. Burden of bloodstream infection in an area of Mid-Norway 2002-2013: a prospective population-based observational study. BMC Infect Dis. 2017;17(1):205.
   PubMedGoogle Scholar
• World Health Organization. Prevention of hospital-acquired infections: a practical guide/editors. G. Ducel, J. Fabry and L. Nicolle, 2nd. ed. World Health Organization 2002. Available from https://apps.who.int/iris/handle/10665/67350.
   Google Scholar
• Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.
   PubMedGoogle Scholar
• Quan H, Li B, Couris CM, et al. Updating and validating the charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6):676–682.
   PubMed Web of Science ®Google Scholar
• Radovanovic D, Seifert B, Urban P, et al. Validity of charlson comorbidity index in patients hospitalised with acute coronary syndrome. Insights from the nationwide AMIS Plus registry 2002-2012. Heart. 2014;100(4):288–294.
   PubMed Web of Science ®Google Scholar
• Le Gall JR, Lemeshow S, Saulnier F. A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. Jama. 1993;270(24):2957–2963.
   PubMed Web of Science ®Google Scholar
• Capuzzo M, Valpondi V, Sgarbi A, et al. Validation of severity scoring systems SAPS II and APACHE II in a single-center population. Intensive Care Med. 2000;26(12):1779–1785.
   PubMed Web of Science ®Google Scholar
• Beck DH, Smith GB, Pappachan JV, et al. External validation of the SAPS II, APACHE II and APACHE III prognostic models in South England: a multicentre study. Intensive Care Med. 2003;29(2):249–256.
   PubMed Web of Science ®Google Scholar
• Helsedirektoratet. Antibiotika i sykehus Oslo: Helsedirektoratet; [updated 2021 May 27; cited 2021 Oct 11]. Available from: https://www.helsedirektoratet.no/retningslinjer/antibiotika-i-sykehus#referere.
   Google Scholar
• NordicAST. Nordic Comittee on Antimicrobial Susceptibility Testing. [cited 2022 July 04]. Available from: https://view.officeapps.live.com/op/view.aspx?src=http%3A%2F%2Fs3-eu-west-1.amazonaws.com%2Fhl-intranet%2Ffiles%2Fb093b042c80456a448f7e88a11f2e864a33c9202%2Fv_9_0_brytningspunkttabell_nordicast_no_final190325_locked.xlsx&wdOrigin=BROWSELINK.
   Google Scholar
• Möller V, Östholm-Balkhed Å, Berild D, et al. Antibiotic resistance among major pathogens compared to hospital treatment guidelines and antibiotic use in nordic hospitals 2010-2018. Infect Dis. 2021;53(8):607–618.
   PubMed Web of Science ®Google Scholar
• Barlam TF, Cosgrove SE, Abbo LM, et al. Implementing an antibiotic stewardship program: guidelines by the infectious diseases society of america and the society for healthcare epidemiology of america. Clin Infect Dis. 2016;62(10):e51–e77.
   PubMed Web of Science ®Google Scholar
• Schuts EC, Hulscher M, Mouton JW, et al. Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis. Lancet Infect Dis. 2016;16(7):847–856.
   PubMed Web of Science ®Google Scholar
• NordicAST. Nordic comittee on antimicrobial susceptibility testing. Available from: https://view.officeapps.live.com/op/view.aspx?src=http%3A%2F%2Fs3-eu-west-1.amazonaws.com%2Fhl-intranet%2Ffiles%2F4474e596b67691fa4ee06ff89f4d3c98f7c568d3%2F200207_v_10_0_nordicast_no_protected.xlsx&wdOrigin=BROWSELINK.
   Google Scholar
• Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181–1247.
   PubMed Web of Science ®Google Scholar
• Sjövall F, Perner A, Hylander Møller M. Empirical mono- versus combination antibiotic therapy in adult intensive care patients with severe sepsis – a systematic review with meta-analysis and trial sequential analysis. J Infect. 2017;74(4):331–344.
   PubMed Web of Science ®Google Scholar
• Ju M, Huang Y, Xu X, et al. Predictors of mortality in adult patients with methicillin-resistant Staphylococcus aureus bloodstream infection: a meta-analysis and systematic review. Ann Palliat Med. 2021;10(8):8617–8627.
   PubMed Web of Science ®Google Scholar
• Corcione S, Mornese Pinna S, Lupia T, et al. Antibiotic De-escalation experience in the setting of emergency department: a retrospective, observational study. J Clin Med. 2021;10(15):3285.
   Web of Science ®Google Scholar
• Lin TL, Chang PH, Chen IL, et al. Risk factors and mortality associated with multidrug-resistant gram-negative bacterial infection in adult patients with abdominal surgery. J Hosp Infect. 2021;119:P22–P32.
   PubMed Web of Science ®Google Scholar
• Baltas I, Stockdale T, Tausan M, et al. Impact of antibiotic timing on mortality from gram-negative bacteraemia in an english district general hospital: the importance of getting it right every time. J Antimicrob Chemother. 2021;76(3):813–819.
   PubMed Web of Science ®Google Scholar
• Gradel KO, Jensen US, Schønheyder HC, et al. Impact of appropriate empirical antibiotic treatment on recurrence and mortality in patients with bacteraemia: a population-based cohort study. BMC Infect Dis. 2017;17(1):122.
   PubMedGoogle Scholar
• Tang Y, Wu X, Cheng Q, et al. Inappropriate initial antimicrobial therapy for hematological malignancies patients with gram-negative bloodstream infections. Infection. 2020;48(1):109–116.
   PubMed Web of Science ®Google Scholar
• Yamaga S, Shime N. Association between appropriate empiric antimicrobial therapy and mortality from bloodstream infections in the intensive care unit. J Infect Chemother. 2018;24(4):267–271.
   PubMed Web of Science ®Google Scholar
• Suppli M, Aabenhus R, Harboe ZB, et al. Mortality in enterococcal bloodstream infections increases with inappropriate antimicrobial therapy. Clin Microbiol Infect. 2011;17(7):1078–1083.
   PubMed Web of Science ®Google Scholar
• Kollef MH, Shorr AF, Bassetti M, et al. Timing of antibiotic therapy in the ICU. Crit Care. 2021;25(1):360.
   PubMed Web of Science ®Google Scholar